Ruan J - Search Results

1

XPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress Tolerance in Cancer Cells.

Marullo R, Rutherford SC, Revuelta MV, Zamponi N, Culjkovic-Kraljacic B, Kotlov N, Di Siervi N, Lara-Garcia J, Allan JN, Ruan J, Furman RR, Chen Z, Shore TB, Phillips AA, Mayer S, Hsu J, van Besien K, Leonard JP, Borden KLB, Inghirami G, Martin P, Cerchietti L. Marullo R, et al. Among authors: ruan j. Cancer Res. 2024 Jan 2;84(1):101-117. doi: 10.1158/0008-5472.CAN-23-1992. Cancer Res. 2024. PMID: 37801604 Free PMC article.

2

New developments in immunotherapy for non-Hodgkin's lymphoma.

Leonard JP, Furman RR, Ruan J, Coleman M. Leonard JP, et al. Among authors: ruan j. Curr Oncol Rep. 2005 Sep;7(5):364-71. doi: 10.1007/s11912-005-0063-4. Curr Oncol Rep. 2005. PMID: 16091197 Review.

3

Mantle cell lymphoma: current concept in biology and treatment.

Ruan J, Leonard JP. Ruan J, et al. Cancer Treat Res. 2006;131:141-59. doi: 10.1007/978-0-387-29346-2_5. Cancer Treat Res. 2006. PMID: 16704169 Review. No abstract available.

4

Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma.

Ruan J, Hyjek E, Kermani P, Christos PJ, Hooper AT, Coleman M, Hempstead B, Leonard JP, Chadburn A, Rafii S. Ruan J, et al. Clin Cancer Res. 2006 Oct 1;12(19):5622-31. doi: 10.1158/1078-0432.CCR-06-1204. Clin Cancer Res. 2006. PMID: 17020964

5

Low-dose metronomic, multidrug therapy with the PEP-C oral combination chemotherapy regimen for mantle cell lymphoma.

Coleman M, Martin P, Ruan J, Furman R, Niesvizky R, Elstrom R, George P, Leonard J, Kaufmann T. Coleman M, et al. Among authors: ruan j. Leuk Lymphoma. 2008 Mar;49(3):447-50. doi: 10.1080/10428190701837330. Leuk Lymphoma. 2008. PMID: 18297520

6

Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP-C) oral combination chemotherapy regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy.

Coleman M, Martin P, Ruan J, Furman R, Niesvizky R, Elstrom R, George P, Kaufman TP, Leonard JP. Coleman M, et al. Among authors: ruan j. Cancer. 2008 May 15;112(10):2228-32. doi: 10.1002/cncr.23422. Cancer. 2008. PMID: 18338745 Free article. Clinical Trial.

7

Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies.

Martin P, Chadburn A, Christos P, Furman R, Ruan J, Joyce MA, Fusco E, Glynn P, Elstrom R, Niesvizky R, Feldman EJ, Shore TB, Schuster MW, Ely S, Knowles DM, Chen-Kiang S, Coleman M, Leonard JP. Martin P, et al. Among authors: ruan j. Ann Oncol. 2008 Jul;19(7):1327-1330. doi: 10.1093/annonc/mdn045. Epub 2008 Mar 17. Ann Oncol. 2008. PMID: 18349031 Free article.

8

Novel and engineered anti-B-cell monoclonal antibodies for non-Hodgkin's lymphoma.

Martin P, Furman RR, Ruan J, Elstrom R, Barrientos J, Niesvizky R, Coleman M, Leonard JP. Martin P, et al. Among authors: ruan j. Semin Hematol. 2008 Apr;45(2):126-32. doi: 10.1053/j.seminhematol.2008.02.007. Semin Hematol. 2008. PMID: 18381108 Review.

9

New monoclonal antibodies for non-Hodgkin's lymphoma.

Leonard JP, Martin P, Ruan J, Elstrom R, Barrientos J, Coleman M, Furman RR. Leonard JP, et al. Among authors: ruan j. Ann Oncol. 2008 Jun;19 Suppl 4:iv60-2. doi: 10.1093/annonc/mdn199. Ann Oncol. 2008. PMID: 18519407 Free article. Review. No abstract available.

10

Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma.

Ruan J, Hajjar K, Rafii S, Leonard JP. Ruan J, et al. Ann Oncol. 2009 Mar;20(3):413-24. doi: 10.1093/annonc/mdn666. Epub 2008 Dec 16. Ann Oncol. 2009. PMID: 19088170 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,266 results

Search Page